Novo Nordisk A/S (NONOF)
126.50
-0.95
(-0.75%)
USD |
OTCM |
Mar 28, 15:59
Novo Nordisk Market Cap: 565.95B for March 28, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
March 27, 2024 | 570.20B |
March 26, 2024 | 578.92B |
March 25, 2024 | 584.29B |
March 22, 2024 | 570.18B |
March 21, 2024 | 579.37B |
March 20, 2024 | 586.22B |
March 19, 2024 | 588.32B |
March 18, 2024 | 591.27B |
March 15, 2024 | 593.91B |
March 14, 2024 | 602.58B |
March 13, 2024 | 593.72B |
March 12, 2024 | 600.62B |
March 11, 2024 | 585.02B |
March 08, 2024 | 588.88B |
March 07, 2024 | 608.23B |
March 06, 2024 | 555.70B |
March 05, 2024 | 559.24B |
March 04, 2024 | 576.24B |
March 01, 2024 | 553.44B |
February 29, 2024 | 532.66B |
February 28, 2024 | 542.46B |
February 27, 2024 | 549.88B |
February 26, 2024 | 550.33B |
February 23, 2024 | 556.55B |
February 22, 2024 | 556.55B |
Date | Value |
---|---|
February 21, 2024 | 533.66B |
February 20, 2024 | 544.25B |
February 16, 2024 | 556.27B |
February 15, 2024 | 543.58B |
February 14, 2024 | 547.36B |
February 13, 2024 | 539.05B |
February 12, 2024 | 543.13B |
February 09, 2024 | 541.34B |
February 08, 2024 | 522.10B |
February 07, 2024 | 534.72B |
February 06, 2024 | 526.13B |
February 05, 2024 | 531.81B |
February 02, 2024 | 501.97B |
February 01, 2024 | 516.23B |
January 31, 2024 | 515.90B |
January 30, 2024 | 496.16B |
January 29, 2024 | 482.73B |
January 26, 2024 | 480.94B |
January 25, 2024 | 468.00B |
January 24, 2024 | 469.31B |
January 23, 2024 | 466.81B |
January 22, 2024 | 471.55B |
January 19, 2024 | 479.83B |
January 18, 2024 | 479.20B |
January 17, 2024 | 476.47B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
110.02B
Minimum
May 16 2019
608.23B
Maximum
Mar 07 2024
240.08B
Average
227.15B
Median
Market Cap Benchmarks
Eli Lilly and Co | 739.70B |
Amgen Inc | 152.35B |
Pfizer Inc | 156.64B |
Johnson & Johnson | 380.95B |
Market Cap Related Metrics
PS Ratio | 12.55 |
PEG Ratio | 1.199 |
Price to Book Value | 42.87 |
Price to Free Cash Flow | 36.72 |
Price | 126.50 |
Earnings Yield | 3.00% |
PEGY Ratio | 1.154 |
Operating PE Ratio | 29.28 |
Normalized PE Ratio | 33.28 |